Hospira Expands Propofol Recall: Shortage Worsens

Only days after we reported on Teva withdrawing from the propofol manufacturing business, the only remaining US manufacturer of propofol expands a recall of the product. Hospira Pharmaceuticals had previously announced a recall in March of 2010 of certain lots of thee drug, even while a nationwide shortage was already in full swing. They have now expanded the recall to include additional lots. Propofol, when available, is the most used intravenous induction agent for general anesthesia in the U.S. The nationwide shortage will not end anytime soon. In fact, as things stand now it will only get worse with no relief in sight.

email
Share

Related Posts

  1. Anesthesia Drug Propofol Shortage Update
  2. Hospira Resumes Propofol Manufacturing
  3. Hospira Ceases Sodium Thiopental Production: Executions In Jeopardy
  4. FDA Article on the Propofol Shortage Appears in NEJM
  5. Teva Abandons Propofol: Drug Shortage Continues…NOW WHAT?
Tags: , , , , ,

2 Responses to Hospira Expands Propofol Recall: Shortage Worsens

  1. [...] have previously reported on the problems over at Hospira Pharmaceuticals which led to propofol recalls and disruption of sodium thiopental production, the anesthetic used to execute people. It just got [...]

  2. [...] have covered the shortages of propofol, sodium thiopental (pentothal), vecuronium and other popular drugs in anesthesia at length. [...]

Leave a Reply

Your email address will not be published. Required fields are marked *

*


*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>